Literature DB >> 30741184

Development of Data Validation Rules for Therapeutic Area Standard Data Elements in Four Mental Health Domains to Improve the Quality of FDA Submissions.

Maryam Garza1, Emel Seker1, Meredith Zozus1.   

Abstract

Data standards are now required for many submissions to the United States Food and Drug Administration (FDA). The required standard for submission of clinical data is the Clinical Data Interchange Standards Consortium (CDISC) Submission Data Tabulation Model (SDTM). Currently, 45 business rules and 115 associated validation rules exist for SDTM data. However, such rules have not yet been developed for therapeutic area data standards developed under the last reauthorization of the Prescription Drug User Fee Act (PDUFA V). The objective of this effort was to develop data validation rules for new therapeutic area data standards in four mental health domains, assess the metadata required to associate such rules with standard data elements, and assess the level of data validation possible for therapeutic area data elements.

Keywords:  CDISC SDTM; data standards; regulatory submissions; therapeutic area standards; validation rules

Mesh:

Year:  2019        PMID: 30741184

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  1 in total

1.  Evaluating the Coverage of the HL7 ® FHIR ® Standard to Support eSource Data Exchange Implementations for use in Multi-Site Clinical Research Studies.

Authors:  Maryam Y Garza; Michael Rutherford; Sahiti Myneni; Susan Fenton; Anita Walden; Umit Topaloglu; Eric Eisenstein; Karan R Kumar; Kanecia O Zimmerman; Mitra Rocca; Gideon Scott Gordon; Sam Hume; Zhan Wang; Meredith Zozus
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.